CRIMSON is a two-year research project (2016-2018) funded by the MS Society and led by Dr Ana Manzano from the Centre for Health, Technologies & Social Practice, University of Leeds. The study aims to improve our understanding of how people with multiple sclerosis weigh up the pros and cons of treatments. It will also help health care professionals to take those preferences into account when helping someone to choose a treatment, in the context of their individual circumstances.
The study will be designed and conducted with the involvement of people with MS, and the findings widely disseminated to cover MS patient groups, clinicians and academic community.